Post by
alexmed95 on Mar 31, 2021 1:58pm
I'm thinking of getting out
If after close, we don't have an update on DLBCL, they will have missed the only target they promised after changing last minute all their previous promised updates. I mean, i'm not even sure I'll be sad to see the stock price at 10$ after getting tf out.
It's starting to become a matter of being respected, more than opportunity cost (which is fuc*ng massive). I feel they lie, and have no shame in changing their "targets" a months before.
Getting out right when I breakeven is an idea that is becoming more and more sexy.
anyway,
GLTA
Comment by
Biotech010 on Mar 31, 2021 4:06pm
i spoke with the company on this deadline. The answer I got was it was a matter of days. Getting the right people to sign in a big organization like Merck isn;t always easy :) So relax... news is coming!
Comment by
Hideaway on Mar 31, 2021 5:04pm
Thanks Biotech.Hope that a matter of days doen't turn into weeks. However, based on the info they gave you,I'll hold on pending news,at least for a bit.Just wondering with whom you spoke,Fred or Pierre or a lesser minon.
Comment by
qwerty22 on Mar 31, 2021 4:22pm
It is certainly not fun, it's definitely frustrating, but my own view is nothing much changes in the investment thesis if they fail to give an update tomorrow. But everybody has to right to judge these things in different ways. I am more tolerant of missed deadlines because I tend to think biotech is hard.
Comment by
Jthom376 on Mar 31, 2021 5:41pm
These missed deadlines affect everybody. Whether you're an institutional investor, or regular guy like myself, their inconsistency leaves a lasting impression. I'm here to stay but I would warn anyone who thinks about investing with them. And you have to know these institutions see it as well.